Pattraporn Tajarernmuang
Overview
Explore the profile of Pattraporn Tajarernmuang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bumroongkit C, Limsukon A, Liwsrisakun C, Deesomchok A, Pothirat C, Theerakittikul T, et al.
J Atheroscler Thromb
. 2023 Mar;
30(11):1601-1611.
PMID: 36967130
Aim: To date, no studies representing the Southeast Asian population have validated the Pulmonary Embolism Severity Index (PESI) and 2019 European Society of Cardiology (ESC) risk stratification. Therefore, this study...
12.
Tajarernmuang P, Sanwirat P, Inchai J, Phinyo P, Limsukon A
Trop Med Infect Dis
. 2023 Feb;
8(2).
PMID: 36828485
This study aimed to assess the predictive performance of the National Early Warning Score 2 (NEWS2) to identify the early progression to severe disease in patients with community-acquired pneumonia (CAP)....
13.
Bumroongkit C, Tajarernmuang P, Trongtrakul K, Liwsrisakun C, Deesomchok A, Pothirat C, et al.
J Cardiovasc Dev Dis
. 2023 Feb;
10(2).
PMID: 36826556
Background: The National Early Warning Scores (NEWS) easily and objectively measures acute clinical deterioration. However, the performance of NEWS to predict mortality in patients with acute pulmonary embolism (APE) is...
14.
Liwsrisakun C, Pata S, Laopajon W, Takheaw N, Chaiwong W, Duangjit P, et al.
Asian Pac J Allergy Immunol
. 2023 Feb;
PMID: 36773278
Background: The concept of heterologous vaccination against SARS-CoV-2 infection has been adopted in Thailand with limited data on the induction of humoral and cellular immunity, particularly the CoronaVac/ChAdOx-1 (CoVac/ChAd) regimen...
15.
Chaiwong W, Takheaw N, Laopajon W, Pata S, Duangjit P, Inchai J, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560586
Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and cellular immune responses after homologous ChAdOx-1 vaccination...
16.
Clinical Characteristics, Risk Factors, and Outcomes of Acute Pulmonary Embolism in Asian Population
Bumroongkit C, Deesomchok A, Liwsrisakun C, Pothirat C, Theerakittikul T, Limsukon A, et al.
J Clin Med
. 2022 Dec;
11(23).
PMID: 36498530
Background: Acute pulmonary embolism (APE) is a common condition with increasing worldwide incidence. However, the clinical characteristics, risk factors, and clinical outcomes of APE in the Asian population especially in...
17.
Dacha S, Chaiwong W, Tajarernmuang P
J Bras Pneumol
. 2022 Nov;
48(5):e20220388.
PMID: 36383782
No abstract available.
18.
Bumroongkit C, Liwsrisakun C, Deesomchok A, Pothirat C, Theerakittikul T, Limsukon A, et al.
Int J Environ Res Public Health
. 2022 Oct;
19(19).
PMID: 36232104
Background: The relationship between the level of air pollution and acute pulmonary embolism (APE) has had inconsistent results. Objective: This study aimed to analyze the relationship between the high level...
19.
Tajarernmuang P, Trongtrakul K, Chaiwong W, Nantsupawat T, Deesomchok A, Chanayat P, et al.
Medicina (Kaunas)
. 2022 Jul;
58(7).
PMID: 35888669
Background and Objective: Bradycardia has been observed among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is suspected to be associated with poorer outcomes. Heart rate (HR)...
20.
Takheaw N, Liwsrisakun C, Chaiwong W, Laopajon W, Pata S, Inchai J, et al.
Diagnostics (Basel)
. 2022 Jun;
12(6).
PMID: 35741126
Various vaccines have been developed to control the COVID-19 pandemic, but the available vaccines were developed using ancestral SARS-CoV-2 wild-type (WT) strains. Commercial anti-SARS-CoV-2 receptor binding domain (RBD) antibody assays...